Figure 3
Figure 3. Analyses of cell populations from lymphoid organs of DO11.10-tg RAG-2−/− mice by flow cytometry 60 days after AAV-EF1α-ova gene transfer. (A) Quantitation of CD25+ of TCR+CD4+, CD25+GITR+ and CD25+CTLA4+ of CD4+ cells from spleen in naive or vector-treated mice. Percentages of dual-positive cells (top-right quadrant) are indicated. Note that AAV-EF1α-ova–transduced mice showed substantial increase in CD25+, CD25+GITR+, and CD25+CTLA4+ of total CD4+ cells compared with control animals. Antibody stain was FITC-conjugated KJ1-26 or CD4, PE-conjugated GITR or CTLA4, and APC-conjugated CD25. Representative examples of FACS density plots are shown for individual samples of splenocytes from DO11.10-tg RAG-2−/− mice. Also graphed are percent GITR+ (B) and CTLA4+ (C) of CD4+CD25+ cells derived from spleen, thymus, portal nodes, and inguinal nodes 60 days after AAV-EF1α-ova gene delivery (B,C).

Analyses of cell populations from lymphoid organs of DO11.10-tg RAG-2−/− mice by flow cytometry 60 days after AAV-EF1α-ova gene transfer. (A) Quantitation of CD25+ of TCR+CD4+, CD25+GITR+ and CD25+CTLA4+ of CD4+ cells from spleen in naive or vector-treated mice. Percentages of dual-positive cells (top-right quadrant) are indicated. Note that AAV-EF1α-ova–transduced mice showed substantial increase in CD25+, CD25+GITR+, and CD25+CTLA4+ of total CD4+ cells compared with control animals. Antibody stain was FITC-conjugated KJ1-26 or CD4, PE-conjugated GITR or CTLA4, and APC-conjugated CD25. Representative examples of FACS density plots are shown for individual samples of splenocytes from DO11.10-tg RAG-2−/− mice. Also graphed are percent GITR+ (B) and CTLA4+ (C) of CD4+CD25+ cells derived from spleen, thymus, portal nodes, and inguinal nodes 60 days after AAV-EF1α-ova gene delivery (B,C).

Close Modal

or Create an Account

Close Modal
Close Modal